MedTrace Logo

Yasmin 20 Cycle Control - Yasmin 20 Versus Mercilon in Healthy Female Volunteers

NCT00624130 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 453

Last updated 2014-12-31

No results posted yet for this study

Summary

The purpose of this study is to compare bleeding pattern of contraceptive Yasmin 20 to a marketed comparator.

Conditions

  • Contraception

Interventions

DRUG

Yasmin 20

Yasmin 20, 24-d regimen vs Mercilon, Tablet p.o. (oral)

DRUG

Mercilon

Mercilon, 24-d regimen vs Yasmin 20 , Tablet p.o. (oral)

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-03-31
Completion
2005-06-30

Countries

  • Austria
  • Estonia
  • Finland
  • Lithuania

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00624130 on ClinicalTrials.gov